Adjunct to diet & exercise to improve glycaemic control in patients w/ type 2 DM as monotherapy or in dual combination w/ metformin, sulphonylurea, thiazolidinedione or insulin when diet, exercise & a single antidiabetic agent do not result in adequate glycaemic control.
Monotherapy 50 or 100 mg daily. In dual combination w/ metformin or thiazolidinedione 50 mg bd (morning & evening). In dual combination w/ sulphonylurea 50 mg once daily in the morning.
Discontinue if acute pancreatitis symptoms (persistent, severe abdominal pain) occur. Monitor liver function. Heart failure; avoid in moderate or severe. Pregnancy. Not to be used during lactation. Not recommended in childn <18 yr.